Search filters

List of works by Lubomir Bodnar

Biomarkers defining probability of receiving second-line targeted therapy in metastatic renal cell carcinoma.

scientific article

Chromophobe renal cell cancer--review of the literature and potential methods of treating metastatic disease.

scientific article published on 07 October 2009

Clinical features and outcomes of germline mutation BRCA1-linked versus sporadic ovarian cancer patients

scientific article

Clinical usefulness of PI3K/Akt/mTOR genotyping in companion with other clinical variables in metastatic renal cell carcinoma patients treated with everolimus in the second and subsequent lines

scientific article published on 10 May 2015

Current management of cervical cancer in Poland-Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations

scientific article published in PLoS ONE

Cystatin C as a marker of glomerular filtration rate in patients with ovarian cancer

scientific article published in April 2008

Cystatin C as a parameter of glomerular filtration rate in patients with ovarian cancer.

scientific article published on 17 August 2010

Cystatin C as a predictor factor in patients with renal cell carcinoma treated by everolimus.

scientific article published on 20 June 2016

Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation

scientific article published on 01 September 2020

EVI1 as a Prognostic and Predictive Biomarker of Clear Cell Renal Cell Carcinoma

scientific article published on 28 January 2020

External validation of the systemic immune-inflammation index as a prognostic factor in metastatic renal cell carcinoma and its implementation within the international metastatic renal cell carcinoma database consortium model

scientific article published on 02 January 2019

Feasibility and efficacy of capecitabine and FOLFIRI in patients aged 65 years and older with advanced colorectal cancer: a retrospective analysis

scientific article published on 20 August 2009

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine Kinase Inhibitors

scientific article

Hypoxia-Mediated Decrease of Ovarian Cancer Cells Reaction to Treatment: Significance for Chemo- and Immunotherapies

scientific article published on 14 December 2020

Impact of COVID-19 on anxiety levels among patients with cancer actively treated with systemic therapy

scientific article published on 01 October 2020

Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model

scientific article published on 3 March 2017

K-Ras gene mutation status as a prognostic and predictive factor in patients with colorectal cancer undergoing irinotecan- or oxaliplatin-based chemotherapy

scientific article

Malignant tumors in patients with end stage renal failure undergoing renal replacement therapy.

scientific article published on 20 November 2012

Metastatic colorectal cancer in the elderly: An overview of the systemic treatment modalities (Review).

scientific article

Mitomycin C and high-dose 5-fluorouracil with folinic acid as a therapeutic option for heavily pretreated patients with metastatic colorectal cancer: prospective phase II trial

scientific article

Mutation of the PIK3CA gene as a prognostic factor in patients with colorectal cancer

scientific article

Overexpression of epidermal growth factor receptor as a prognostic factor in colorectal cancer on the basis of the Allred scoring system.

scientific article published on 24 July 2013

Plasma and ovarian tissue sphingolipids profiling in patients with advanced ovarian cancer

scientific article published on 8 August 2017

Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data

scientific article published on 12 October 2020

Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors

scientific article published in January 2018

Prognostic significance of Wnt-1, β-catenin and E-cadherin expression in advanced colorectal carcinoma.

scientific article

Real-world Experience of Cabozantinib as Second- or Subsequent Line Treatment in Patients With Metastatic Renal Cell Carcinoma: Data From the Polish Managed Access Program

scientific article published on 20 February 2019

Recommendations of the Fertility Preservation Working Group in Oncological, Hematological and Other Patients Treated With Gonadotoxic Therapies "ONCOFERTILITY" (GROF) of the Polish Society of Oncological Gynecology

scientific article published on 28 June 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis and treatment of ovarian cancer

scientific article published on 31 May 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of cervical cancer

scientific article published on 31 May 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of endometrial cancer

scientific article published on 31 May 2017

Recommendations of the Polish Gynecological Oncology Society for the diagnosis andtreatment of vulvar cancer

scientific article published on 31 May 2017

Renal protection with magnesium subcarbonate and magnesium sulphate in patients with epithelial ovarian cancer after cisplatin and paclitaxel chemotherapy: a randomised phase II study.

scientific article

Resistance to first line platinum paclitaxel chemotherapy in serous epithelial ovarian cancer: the prediction value of ERCC1 and Tau expression

scientific article published on 27 February 2014

Role of WNT/β-Catenin Pathway as Potential Prognostic and Predictive Factors in Renal Cell Cancer Patients Treated With Everolimus in the Second and Subsequent Lines

scientific article published on 02 February 2018

Salvage therapy with topotecan in heavily pretreated ovarian cancer patients

scientific article published on 26 November 2008

Screening for ovarian cancer in BRCA1/BRCA2 mutations carriers

scientific article

Serous peritoneal psammocarcinoma with an aggressive course: a case and review of the literature.

scientific article published on August 2009

Serum TRAIL levels in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy. A pilot study

scientific article published on 01 January 2011

Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib

scientific article published on 4 October 2012

Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: a phase II study

scientific article published on 01 July 2011

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

scientific article

Survivin expression as a prognostic factor in patients with epithelial ovarian cancer or primary peritoneal cancer treated with neoadjuvant chemotherapy.

scientific article

Tau protein as a potential predictive marker in epithelial ovarian cancer patients treated with paclitaxel/platinum first-line chemotherapy.

scientific article published on 30 April 2013

The impact of oophorectomy on survival from breast cancer in patients with CHEK2 mutations

scientific article published in July 2022

The role of Tau protein in resistance to paclitaxel

scientific article published on 29 June 2011

Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review

scientific article published on June 2013

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer

scientific article published on 06 February 2014

[CA 125 regression after two cycles of neoadjuvant chemotherapy as prognostic factor in patients with advanced ovarian cancer and primary peritoneal serous cancer who underwent interval surgical cytoreduction]

scientific article published on 01 February 2008

[Surgical treatment in ovarian cancer prevention in carriers of the BRCA1/BRCA2 mutation]

scientific article published on 01 January 2012

Paulina is supported by:

About Paulina

Help